Výsledky vyhledávání - "Steven F Mandish"

Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy

Autor: Brian J. Williams, Dale Ding, Mayur Sharma, M.E. May, Alexandria L. Oliver, Steven F Mandish, Donald R. Miller, Jeremy Gaskins, Eric Burton, Abbas Rattani, Mehran Yusuf, Shiao Y. Woo

Publikováno v: Journal of Neuro-Oncology

Purpose/objective(s) To determine, for intact melanoma brain metastases (MBM) treated with single-fraction stereotactic radiosurgery (SRS), whether planning parameter peripheral dose per lesion diameter (PDLDm, Gy/mm) and lesion control (LC) differs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a8296162452ceca895c9114ae858ea
http://europepmc.org/articles/PMC8606626

Zobrazit plný text záznamu

Immune Status in Merkel Cell Carcinoma: Relationships With Clinical Factors and Independent Prognostic Value

Autor: Steven F Mandish, Jeffrey M. Bumpous, Weston Wall, Abbas Rattani, Grant McKenzie, Alyssa Farley, Neal Dunlap, Jeremy Gaskins, Paul Tennant, Mehran Yusuf

Publikováno v: Annals of Surgical Oncology. 28:6154-6165

e21509 Background: Immunosuppression (IS) is not currently considered in staging for Merkel cell carcinoma (MCC). We performed an analysis of the National Cancer Database (NCDB) to investigate immune status as an independent predictor of overall surv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a87d710d229ebb0877d581d9627034
https://doi.org/10.1245/s10434-021-09944-6

Zobrazit plný text záznamu

The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response

Autor: Yomna Amer, Steven F Mandish, Jeremy Gaskins, Mehran Yusuf, Harriet Eldredge-Hindy

Publikováno v: Acta Oncologica. 59:1210-1217

Neoadjuvant chemotherapy (NAC) is a standard of care for locally advanced breast cancers. Adjuvant radiotherapy (RT) after NAC is an area of active research. We hypothesize overall survival (OS) is not altered by omitting RT in women with a pathologi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd67e4cbc0f5c4125e0b6630ecc27ab9
https://doi.org/10.1080/0284186x.2020.1797161

Zobrazit plný text záznamu

Plný text ve formátu HTML

Tumor infiltrating lymphocyte grade in Merkel cell carcinoma: relationships with clinical factors and independent prognostic value

Autor: Jeffrey B. Jorgensen, Jeremy Gaskins, M.E. May, Jeffrey M. Bumpous, W. Fisher, Neal Dunlap, Weston Wall, Paul Tennant, Mehran Yusuf, Steven F Mandish

Publikováno v: Acta Oncologica. 59:1409-1415

Surrogate markers of the host immune response are not currently included in AJCC staging for Merkel cell carcinoma (MCC), and have not been consistently associated with clinical outcomes. We performed an analysis of a large national database to inves

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc709efc8fbef5fbb66aa1839bb5f510
https://doi.org/10.1080/0284186x.2020.1794033

Zobrazit plný text záznamu

Plný text ve formátu HTML

Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival

Autor: Scott M, Glaser, Steven F, Mandish, Beant S, Gill, Goundappa K, Balasubramani, David A, Clump, Sushil, Beriwal

Publikováno v: Headneck. 38

Anaplastic thyroid cancer (ATC) represents a rare, aggressive malignancy. We analyzed factors predictive for overall survival (OS) and treatment modality utilization.Using the National Cancer Data Base, we identified 3552 patients with ATC. Factors a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0ed49fba46bdcf99d889312b0b8901ab
https://pubmed.ncbi.nlm.nih.gov/26894506

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání